首页> 外文期刊>Diseases of the Colon and Rectum >The efficacy of self-expanding metal stents for malignant colorectal obstruction by noncolonic malignancy with peritoneal carcinomatosis
【24h】

The efficacy of self-expanding metal stents for malignant colorectal obstruction by noncolonic malignancy with peritoneal carcinomatosis

机译:自膨式金属支架治疗非结肠癌伴腹膜癌恶性大肠梗阻的疗效

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Although self-expanding metal stents for colorectal obstruction is preferred over emergency surgery, the efficacy of self-expanding metal stents in patients with malignant colorectal obstruction by a noncolonic malignancy with peritoneal carcinomatosis has not been demonstrated. OBJECTIVE: The aim of this study was to evaluate the survival and long-term clinical outcome of selfexpanding metal stents as the initial interventional approach in patients with malignant colorectal obstruction due to a noncolonic malignancy with peritoneal carcinomatosis. DESIGN: This is a retrospective study. SETTINGS: This study was conducted at 2 tertiary care academic medical centers in South Korea. PATIENTS: The patients were included who underwent self-expanding metal stent insertion for palliation of a malignant colorectal obstruction by a noncolonic malignancy with peritoneal carcinomatosis between July 2004 and January 2010. Inclusion criteria were incurable status, noncolorectal cancer, obstructive symptoms and/ or signs, and colonoscopic findings of obstruction. MAIN OUTCOME MEASURES: The survival and success rate of patients undergoing self-expanding metal stents insertion was assessed. RESULTS: Twenty patients were included during the study period. Technical success of self-expanding metal stents was achieved in 18/20 (90.0%) patients, and obstructive symptoms were resolved within 72 hours in 17/20 (85.0%) patients. Ten patients (10/20, 50%) did not need further intervention during the follow-up period after the first stent insertion. Eight patients ultimately underwent surgery during the follow-up period. One of the remaining 2 patients underwent additional endoscopic treatment without surgery. Another patient refused further intervention and thus received conservative management. Mean event-free survival was 119.0 days, and the mean overall survival of the included patients was 156.3 days. LIMITATION: The number of study patients was small. CONCLUSION: Self-expanding metal stent insertion appears to be a reasonable first-treatment option in patients with malignant colorectal obstruction by noncolonic malignancy with peritoneal carcinomatosis.
机译:背景:尽管自膨式金属支架治疗结直肠梗阻优于急诊手术,但尚未证明自膨式金属支架治疗非结肠癌伴腹膜癌的恶性大肠梗阻患者的疗效。目的:本研究旨在评估自扩张金属支架的生存率和长期临床疗效,作为非结肠癌伴腹膜癌的恶性大肠梗阻患者的初步干预方法。设计:这是一项回顾性研究。地点:这项研究是在韩国的两个三级护理学术医学中心进行的。患者:2004年7月至2010年1月间,接受自扩张金属支架置入术以缓解非结肠癌伴腹膜癌的恶性大肠梗阻的患者。入选标准为无法治愈的状态,非大肠癌,阻塞性症状和/或体征,以及结肠镜检查发现的阻塞。主要观察指标:评估接受自扩张金属支架置入术的患者的生存和成功率。结果:在研究期间纳入了20名患者。 18/20(90.0%)患者获得了自膨胀金属支架的技术成功,17/20(85.0%)患者在72小时内解决了阻塞性症状。首次置入支架后的随访期间,有10名患者(10/20,50%)无需进一步干预。八名患者最终在随访期间接受了手术。其余2例患者中有1例未经手术接受了额外的内镜治疗。另一名患者拒绝进一步干预,因此接受了保守治疗。无事件的平均生存期为119.0天,纳入患者的平均总生存期为156.3天。局限性:研究患者的数量很少。结论:对于非结肠癌伴腹膜癌的恶性大肠梗阻患者,自膨式金属支架置入似乎是合理的首选治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号